獣医用PoC診断市場規模、シェア、動向、2031年までの世界予測

獣医用PoC診断市場は、2026年の11億9,000万米ドルから2031年には17億2,000万米ドルへと成長し、年平均成長率（CAGR）は7.7%になると予測されています。

この成長は、迅速な獣医診断、分散型検査、リアルタイムの動物健康管理といった未来を形作るいくつかの重要な要因によって牽引されています。

獣医療におけるPoC診断市場は、主にペットや家畜における診療現場での疾病特定への注目の高まりによって牽引されており、迅速な臨床意思決定の必要性が高まっています。ペット飼育の増加と畜産集約化の傾向は、獣医師や動物医療サービス提供者に早期発見と定期的な健康モニタリングを重視するよう促し、疾病負担の軽減と治療管理の改善に役立てています。その結果、動物病院、農場、現場獣医師は、迅速な疾病特定のために、迅速免疫測定法、携帯型分子システム、携帯型分析装置などのPoC機器をますます活用するようになっています。

調査範囲

本市場調査は、獣医用PoC（ポイントオブケア）診断市場を様々なセグメントに分けて分析しています。製品、技術、動物の種類、地域別に市場規模と成長可能性を推定することを目的としています。また、主要企業の詳細な競合分析、企業プロファイル、製品および事業内容に関する重要な考察、最近の動向、主要な市場戦略についても詳述しています。

本レポートを購入する理由

本レポートは、既存企業はもちろん、新規参入企業や中小企業が市場動向を理解し、より大きな市場シェアを獲得するのに役立ちます。本レポートを購入した企業は、以下に概説する5つの戦略のうち、1つ以上を実行することができます。

本レポートでは、以下の点について考察します。

獣医用PoC診断市場の成長に影響を与える主要な推進要因（迅速な現場診断と即時的な臨床意思決定への需要の高まり、ペット飼育の増加、畜産生産の集約化）、阻害要因（一部のケースにおける中央検査室での検査と比較した感度・精度の限界、高度なPoC機器の高コスト、低所得地域での普及の遅れ）、機会（携帯型分子診断およびバイオセンサーにおける技術革新、獣医療インフラが拡大する新興市場における普及の拡大）、課題（標準化の欠如と地域ごとの規制の違い、PoC検査の適切な使用と解釈のための熟練した専門家の不足）の分析

• 製品開発／イノベーション：獣医用PoC診断市場における今後の技術と製品発売に関する詳細な考察
• 市場開発：地域ごとの様々なタイプのPoC診断製品市場を分析することで、有望な新興市場に関する包括的な情報を提供
• 市場の多様化：製品、未開拓地域、最新の動向に関する包括的な情報獣医用PoC診断市場における開発動向と投資
• 競合分析：獣医用PoC診断市場における主要企業の市場シェア、戦略、製品、流通ネットワーク、製造能力に関する詳細な分析

Report Description

The veterinary PoC diagnostics market is expected to grow from USD 1.19 billion in 2026 to USD 1.72 billion by 2031, at a CAGR of 7.7%. This growth is driven by several key factors shaping the future of rapid veterinary diagnostics, decentralized testing, and real-time animal health management.

The veterinary PoC diagnostics market is primarily driven by increasing focus on disease identification at the point of care in companion and farm animals, fueling the need for rapid clinical decision-making. The growing trend of pet ownership and livestock intensification is pushing veterinarians and animal health service providers to emphasize early detection and regular health monitoring, helping them reduce the disease burden and improve treatment management. Consequently, veterinary clinics, farms and field veterinarians are increasingly employing point-of-care instruments such as rapid immunoassays, portable molecular systems, and handheld analyzers for rapid disease identification.

Another key driver is the growing focus on animal health prevention, biosecurity and management of zoonotic and economically important diseases. Governments, veterinary associations, and animal owners are placing greater focus on disease monitoring and surveillance to reduce the number of disease outbreaks and safeguard food safety and public health. This is increasing the demand for PoC testing for rapid disease detection and treatment decision-making.

In addition, while the current PoC diagnostic market is still in development, improvements in diagnostic technology, in particular smaller and more portable diagnostic devices, isothermal amplification techniques, and integrated digital platforms, are improving the potency and viability of PoC diagnostic tools. Developments including cartridge-based approaches, ready-to-use diagnostic kits, and connected diagnostic devices will greatly reduce testing times, automate processes, and make the wider use of PoC diagnostics more feasible.

By animal type, companion animals to record higher CAGR during forecast period

The companion animals segment is expected to witness a higher growth rate in the veterinary PoC diagnostics market due to the rising global pet population and increasing humanization of pets, leading to higher spending on advanced veterinary care. Pet owners are increasingly demanding rapid, in-clinic diagnostics for early disease detection and immediate treatment decisions, driving adoption of PoC technologies in veterinary clinics. Additionally, greater awareness of preventive healthcare, frequent veterinary visits, and the availability of advanced, user-friendly diagnostic solutions tailored for companion animals are further accelerating growth in this segment.

By technology, immunodiagnostics segment accounted for largest market share in 2025

In 2025, the immunodiagnostics segment dominated the veterinary PoC diagnostics market due to its widespread use in rapid, easy-to-perform testing formats such as lateral flow assays and ELISA-based kits. These tests are commonly used to detect infectious diseases, parasites, and biomarkers across both companion and livestock animals, making them integral to routine veterinary practice. Their advantages, including quick turnaround time, cost-effectiveness, minimal sample preparation, and suitability for in-clinic and field settings without advanced infrastructure, drive high adoption volumes and make immunodiagnostics the dominant segment in the market.

Asia Pacific to witness highest growth rate during forecast period

The Asia Pacific region is growing at the fastest rate in the veterinary PoC diagnostics market. The main reason for this is due to rising livestock production, pet ownership, and awareness of animal health management in emerging countries of the region. Pet adoption is increasing in many emerging nations, coupled with the rising use of portable, rapid diagnostic products in clinical and farm settings due to expanding veterinary infrastructure and government initiatives for disease surveillance and control. The growing incidence of infectious and zoonotic diseases and an increase in investments by global and regional players are leading to the wide adoption of portable, user-friendly veterinary PoC diagnostics.

Breakdown of supply-side primary interviews:

• By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%)
• By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%)
• By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)

Note: C-level executives include CEOs, COOs, CTOs, and VPs.

Other designations include sales, marketing, and product managers.

Breakdown of demand-side primary interviews:

• By End User: Veterinary Hospitals & Clinics (50%), Homecare Settings (35%), Other End Users (15%)
• By Designation: Veterinarians/Veterinary Practitioners (47%), Veterinary Clinics or Hospital Directors/Owners (22%), Livestock Farm Managers/Animal Health Managers (15%), and Others (16%)
• By Region: North America (25%), Europe (24%), Asia Pacific (25%), Latin America (11%), and the Middle East & Africa (15%)

Note: Other end users include academic and research institutes,  livestock farm owners, and animal welfare organizations.

Note: Other designations include laboratory technicians, practice managers, procurement officers, and academic researchers.

Research Coverage

The market study covers the veterinary PoC diagnostics market in various segments. It aims to estimate the market size and growth potential of this market by product, technology, animal type, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.

This report provides insights into the following points:

Analysis of key drivers (rising demand for rapid, on-site diagnosis and immediate clinical decision-making, increasing pet ownership and intensification of livestock production), restraints (limited sensitivity/accuracy compared to centralized laboratory testing in some cases, high cost of advanced PoC devices and limited adoption in low-income regions), opportunities (technological advancements in portable molecular diagnostics and biosensors, growing adoption in emerging markets with expanding veterinary infrastructure), and challenges (lack of standardization and regulatory variations across regions, limited skilled professionals for proper use and interpretation of PoC tests) influencing the growth of the veterinary PoC diagnostics market

• Product Development/Innovation: Detailed insights on upcoming technologies and product launches in the veterinary PoC diagnostics market
• Market Development: Comprehensive information about lucrative emerging markets by analyzing the markets for various types of PoC diagnostic products across regions
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the veterinary PoC diagnostics market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the veterinary PoC diagnostics market

Table of Contents

1 INTRODUCTION 33
1.1 STUDY OBJECTIVES 33
1.2 MARKET DEFINITION 33
1.3 MARKET SCOPE 34
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 34
1.3.2 INCLUSIONS AND EXCLUSIONS 35
1.3.3 YEARS CONSIDERED 35
1.3.4 CURRENCY CONSIDERED 36
1.3.5 UNIT CONSIDERED 36
1.4 LIMITATIONS 36
1.5 STAKEHOLDERS 36
1.6 SUMMARY OF CHANGES 37
2 EXECUTIVE SUMMARY 38
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 38
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 39
2.3 DISRUPTIVE TRENDS IN VETERINARY POC DIAGNOSTICS MARKET 40
2.4 HIGH-GROWTH SEGMENTS 41
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 42
3 PREMIUM INSIGHTS 44
3.1 VETERINARY POC DIAGNOSTICS MARKET OVERVIEW 44
3.2 VETERINARY POC DIAGNOSTICS MARKET IN ASIA PACIFIC, BY PRODUCT AND COUNTRY 45
3.3 VETERINARY POC DIAGNOSTICS MARKET: REGIONAL MIX 46
3.4 VETERINARY POC DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 46
3.5 VETERINARY POC DIAGNOSTICS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 47
4 MARKET OVERVIEW 48
4.1 INTRODUCTION 48
4.2 MARKET DYNAMICS 48
4.2.1 DRIVERS 49
4.2.1.1 Rising incidence of transboundary and endemic diseases 49
4.2.1.2 Increasing demand for animal-derived food products 49
4.2.1.3 Technological advancements in molecular diagnostics, multiplex assays, and rapid testing platforms 50
4.2.1.4 Growth in companion animal population 51
4.2.1.5 Rising demand for pet insurance and growing animal health expenditure 52

4.2.2 RESTRAINTS 53
4.2.2.1 Rising pet care costs 53
4.2.2.2 High cost of veterinary diagnostic tests 54
4.2.2.3 Limited diagnostic infrastructure in emerging economies 54
4.2.3 OPPORTUNITIES 55
4.2.3.1 Integration of AI & ML in veterinary PoC diagnostics 55
4.2.3.2 Expansion of rapid PoC and portable on-farm diagnostic solutions 55
4.2.4 CHALLENGES 56
4.2.4.1 Rapid mutation and strain variability of viral pathogens 56
4.3 UNMET NEEDS AND WHITE SPACES 56
4.3.1 UNMET NEEDS IN VETERINARY POC DIAGNOSTICS MARKET 56
4.3.2 WHITE SPACE OPPORTUNITIES 57
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 58
4.4.1 INTERCONNECTED MARKETS 58
4.4.2 CROSS-SECTOR OPPORTUNITIES 59
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 60
4.5.1 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 60
5 INDUSTRY TRENDS 61
5.1 PORTER’S FIVE FORCES ANALYSIS 61
5.1.1 THREAT OF NEW ENTRANTS 62
5.1.2 THREAT OF SUBSTITUTES 62
5.1.3 BARGAINING POWER OF SUPPLIERS 63
5.1.4 BARGAINING POWER OF BUYERS 63
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 63
5.2 MACROECONOMIC OUTLOOK 64
5.2.1 INTRODUCTION 64
5.2.2 GDP TRENDS AND FORECAST 64
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 65
5.2.4 TRENDS IN GLOBAL ANIMAL HEALTH INDUSTRY 66
5.3 VALUE CHAIN ANALYSIS 66
5.4 ECOSYSTEM ANALYSIS 68
5.5 PRICING ANALYSIS 68
5.5.1 PRICING TREND OF VETERINARY POC DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2023–2025 69
5.5.1.1 Pricing trend of veterinary PoC diagnostic products, by key player, 2023−2025 69
5.5.2 PRICING TREND OF VETERINARY POC DIAGNOSTIC PRODUCTS, BY REGION, 2023–2025 69
5.5.2.1 Pricing trend of PCR kits, by region, 2023−2025 70
5.5.2.2 Pricing trend of immunodiagnostic veterinary POC products, by region, 2023−2025 70

5.6 TRADE ANALYSIS 71
5.6.1 TRADE DATA FOR HS CODE 3822-COMPLIANT PRODUCTS 72
5.6.1.1 Country-wise import data for HS code 3822-compliant products, 2021–2025 72
5.6.1.2 Country-wise export data for HS code 3822-compliant products, 2021–2025 72
5.7 KEY CONFERENCES AND EVENTS, 2026–2027 73
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 74
5.9 INVESTMENT AND FUNDING SCENARIO 75
5.10 CASE STUDY ANALYSIS 76
5.10.1 USE OF AI-POWERED POULTRY DISEASE DIAGNOSTICS FOR COCCIDIOSIS & SALMONELLA DETECTION 76
5.10.2 ADOPTION OF AI-ENABLED POC DIAGNOSTIC PLATFORM FOR PARASITE DETECTION 77
5.10.3 DEVELOPMENT OF SNAP 4DX PLUS TEST FOR RAPID VECTOR-BORNE DISEASE DETECTION 77
5.11 IMPACT OF US TARIFFS ON VETERINARY POC DIAGNOSTICS MARKET 78
5.11.1 INTRODUCTION 78
5.11.2 KEY TARIFF RATES 79
5.11.3 PRICE IMPACT ANALYSIS 80
5.11.4 IMPACT ON COUNTRY/REGION 80
5.11.5 IMPACT ON END USERS 82
5.11.5.1 Veterinary hospitals & clinics 82
5.11.5.2 Livestock producers & animal health networks 82
5.11.5.3 Home care settings 82
5.11.5.4 Other end users (mobile veterinary service providers, animal shelters, NGOs) 82
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 83
6.1 KEY/EMERGING TECHNOLOGIES 83
6.1.1 CRISPR-BASED MOLECULAR DIAGNOSTICS 83
6.1.2 ISOTHERMAL AMPLIFICATION AND PAPER-BASED LAMP 83
6.2 COMPLEMENTARY TECHNOLOGIES 84
6.2.1 MICROFLUIDICS & LAB-ON-A-CHIP DEVICES 84
6.2.2 BIOSENSOR-BASED DIAGNOSTIC SYSTEMS 84
6.3 ADJACENT TECHNOLOGIES 85
6.3.1 AI & MACHINE LEARNING 85
6.3.2 WEARABLE BIOSENSORS & REMOTE MONITORING DEVICES 85
6.4 TECHNOLOGY/PRODUCT ROADMAP 86
6.4.1 NEAR TERM (2025–2027) 86
6.4.2 MID TERM (2028–2030) 86
6.4.3 LONG TERM (2030+) 87
6.5 PATENT ANALYSIS 87
6.5.1 PATENT PUBLICATION TRENDS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS 87
6.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 88
6.6 FUTURE APPLICATIONS 90
6.6.1 PRECISION FLOCK-LEVEL DISEASE PREDICTION 90
6.6.2 MINI FULLY INTEGRATED ON-FARM MOLECULAR TESTING PLATFORMS 91
6.6.3 MULTIPLEX AND SYNDROMIC VETERINARY DIAGNOSTIC PANELS 91
6.6.4 SMART BIOSENSOR-ENABLED REAL-TIME HEALTH MONITORING 91
6.7 IMPACT OF AI/GENERATIVE AI ON VETERINARY POC DIAGNOSTICS MARKET 91
6.7.1 INTRODUCTION 91
6.7.2 MARKET POTENTIAL IN VETERINARY POC DIAGNOSTIC ECOSYSTEM 92
6.7.3 AI USE CASES 92
6.7.4 KEY COMPANIES IMPLEMENTING AI IN VETERINARY POC DIAGNOSTICS MARKET 93
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 94
7.1 REGIONAL REGULATIONS AND COMPLIANCE 94
7.1.1 REGULATORY ANALYSIS 94
7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
7.1.3 INDUSTRY STANDARDS 97
7.2 SUSTAINABILITY INITIATIVES 98
7.2.1 RECYCLED AND ECO-FRIENDLY MATERIALS FOR VETERINARY POC DIAGNOSTIC PRODUCTS 98
7.2.2 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 98
7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 99
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 100
8.1 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 100
8.1.1 DECISION-MAKING PROCESS 100
8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 101
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 101
8.2.2 BUYING CRITERIA 101
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 103
8.3.1 UNMET NEEDS OF VARIOUS END USERS 104
8.4 MARKET PROFITABILITY 104

9 VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT 106
9.1 INTRODUCTION 107
9.2 CONSUMABLES 109
9.2.1 INCREASING PREVALENCE OF INFECTIOUS AND ZOONOTIC DISEASES IN ANIMALS TO BOOST DEMAND 109
9.2.2 GLOBAL VOLUME ANALYSIS OF CONSUMABLES,
2024–2031 (THOUSAND UNITS) 111
9.3 INSTRUMENTS 112
9.3.1 SURGING DEMAND FOR PORTABLE AND AUTOMATED DIAGNOSTIC SYSTEMS TO ACCELERATE MARKET GROWTH 112
9.3.2 GLOBAL VOLUME ANALYSIS OF INSTRUMENTS, 2024–2031 (THOUSAND UNITS) 114
10 VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE 115
10.1 INTRODUCTION 116
10.2 COMPANION ANIMALS 116
10.2.1 GROWING PET ADOPTION DUE TO RISING URBANIZATION TO FACILITATE MARKET GROWTH 116
10.2.2 DOG 119
10.2.2.1 Increasing prevalence of canine infectious diseases to support rapid adoption of veterinary care 119
10.2.3 CAT 121
10.2.3.1 Growing awareness of feline infectious diseases to fuel market growth 121
10.2.4 HORSE 122
10.2.4.1 Need to prevent vertical pathogen transmission to stimulate use of extensive PCR surveillance solutions 122
10.2.5 OTHER COMPANION ANIMALS 124
10.3 LIVESTOCK 125
10.3.1 SUSCEPTIBILITY OF LIVESTOCK TO FOOT-AND-MOUTH DISEASE, CLASSICAL SWINE FEVER, AVIAN INFLUENZA TO PROMOTE ADOPTION OF DIAGNOSTIC PRODUCTS 125
10.3.2 CATTLE 128
10.3.2.1 Increasing focus on improving milk quality, herd productivity, and biosecurity management to drive demand 128
10.3.3 PIG 130
10.3.3.1 Growing swine disease outbreaks to accelerate diagnostic utilization 130
10.3.4 POULTRY 131
10.3.4.1 Rrising concerns regarding zoonotic disease transmission to spur demand 131
10.3.5 OTHER LIVESTOCK 133

11 VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY 135
11.1 INTRODUCTION 136
11.2 IMMUNODIAGNOSTICS 137
11.2.1 PRESSING NEED FOR RAPID AND COST-EFFECTIVE INFECTIOUS DISEASE TESTING TO CONTRIBUTE TO MARKET GROWTH 137
11.3 MOLECULAR DIAGNOSTICS 139
11.3.1 PCR-BASED 142
11.3.1.1 Increasing use of portable and multiplex PCR platforms to propel market 142
11.3.2 ISOTHERMAL AMPLIFICATION 143
11.3.2.1 Demand for rapid and low-infrastructure molecular testing to accelerate adoption 143
11.3.3 CRISPR-BASED 145
11.3.3.1 Emerging next-generation pathogen detection technologies to create growth potential 145
11.4 OTHER TECHNOLOGIES 146
12 VETERINARY POC DIAGNOSTICS MARKET, BY REGION 148
12.1 INTRODUCTION 149
12.2 NORTH AMERICA 150
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 151
12.2.2 NORTH AMERICA: VOLUME ANALYSIS, BY PRODUCT, 2024–2031 152
12.2.3 US 155
12.2.3.1 High veterinary healthcare expenditure to drive market 155
12.2.4 CANADA 158
12.2.4.1 Growing pet adoption to drive market 158
12.3 EUROPE 161
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 162
12.3.2 EUROPE: VOLUME ANALYSIS, BY PRODUCT, 2024–2031 162
12.3.3 GERMANY 165
12.3.3.1 Rising awareness of zoonotic diseases to fuel market growth 165
12.3.4 UK 169
12.3.4.1 Increasing pet ownership to stimulate demand 169
12.3.5 FRANCE 172
12.3.5.1 Willingness of pet owners to spend on pet health to promote market growth 172
12.3.6 ITALY 175
12.3.6.1 Growing consumption of meat and dairy products to drive market 175
12.3.7 SPAIN 178
12.3.7.1 Growing demand for poultry products to fuel market growth 178
12.3.8 NETHERLANDS 180
12.3.8.1 Developments in veterinary diagnostic products to support market growth 180
12.3.9 POLAND 183
12.3.9.1 Rapid expansion of poultry production and export-oriented farming to elevate demand 183
12.3.10 SWEDEN 186
12.3.10.1 Strong veterinary healthcare infrastructure and advanced animal welfare regulations to propel market 186
12.3.11 REST OF EUROPE 189
12.4 ASIA PACIFIC 191
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 193
12.4.2 ASIA PACIFIC: VOLUME ANALYSIS, BY PRODUCT, 2024–2031 194
12.4.3 CHINA 197
12.4.3.1 Increasing incidence of zoonotic diseases to propel market 197
12.4.4 JAPAN 200
12.4.4.1 Increasing pet expenditure to support market growth 200
12.4.5 INDIA 204
12.4.5.1 Increasing demand for dairy products to drive market 204
12.4.6 AUSTRALIA 207
12.4.6.1 Rise in pet ownership to support market growth 207
12.4.7 SOUTH KOREA 210
12.4.7.1 Rising need for specialized veterinary services to drive market 210
12.4.8 NEW ZEALAND 213
12.4.8.1 Focus on pet insurance to aid market 213
12.4.9 THAILAND 216
12.4.9.1 Growing focus on disease surveillance to drive market 216
12.4.10 REST OF ASIA PACIFIC 219
12.5 LATIN AMERICA 221
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 222
12.5.2 LATIN AMERICA: VOLUME ANALYSIS, BY PRODUCT, 2024–2031 222
12.5.3 BRAZIL 225
12.5.3.1 Booming livestock industry to boost demand 225
12.5.4 MEXICO 228
12.5.4.1 Expanding poultry sector to support market growth 228
12.5.5 ARGENTINA 231
12.5.5.1 Expanding poultry production and increasing focus on disease monitoring to drive market 231
12.5.6 REST OF LATIN AMERICA 234
12.6 MIDDLE EAST & AFRICA 236
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 237
12.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY PRODUCT, 2024–2031 237
12.6.3 GCC COUNTRIES 240
12.6.3.1 Kingdom of Saudi Arabia (KSA) 243
12.6.3.1.1 Technology advancements in veterinary diagnostics to boost demand 243
12.6.3.2 United Arab Emirates (UAE) 245
12.6.3.2.1 Favorable government support for vet diagnostics to drive market 245
12.6.3.3 Rest of GCC Countries 248
12.6.4 REST OF MIDDLE EAST & AFRICA 250
13 COMPETITIVE LANDSCAPE 253
13.1 OVERVIEW 253
13.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, JANUARY 2022–APRIL 2026 253
13.3 REVENUE ANALYSIS, 2021−2025 255
13.4 MARKET SHARE ANALYSIS, 2025 257
13.4.1 US MARKET SHARE ANALYSIS, 2025 259
13.4.2 EUROPE MARKET SHARE ANALYSIS, 2025 260
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 261
13.5.1 STARS 261
13.5.2 EMERGING LEADERS 261
13.5.3 PERVASIVE PLAYERS 261
13.5.4 PARTICIPANTS 261
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 263
13.5.5.1 Company footprint 263
13.5.5.2 Region footprint 264
13.5.5.3 Product footprint 265
13.5.5.4 Technology footprint 266
13.5.5.5 Animal type footprint 267
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 267
13.6.1 PROGRESSIVE COMPANIES 267
13.6.2 RESPONSIVE COMPANIES 268
13.6.3 DYNAMIC COMPANIES 268
13.6.4 STARTING BLOCKS 268
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 269
13.6.5.1 Detailed list of key startups/SMEs 269
13.6.5.2 Competitive benchmarking of key startups/SMEs 270
13.7 BRAND/PRODUCT COMPARISON 271
13.8 R&D EXPENDITURE OF KEY PLAYERS 272
13.9 COMPANY VALUATION AND FINANCIAL METRICS 272
13.9.1 FINANCIAL METRICS 272
13.9.2 COMPANY VALUATION 273
13.10 COMPETITIVE SCENARIO 273
13.10.1 PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS 273
13.10.2 DEALS 274
13.10.3 EXPANSIONS 275
13.10.4 OTHER DEVELOPMENTS 276
14 COMPANY PROFILES 277
14.1 KEY PLAYERS 277
14.1.1 IDEXX LABORATORIES, INC. 277
14.1.1.1 Business overview 277
14.1.1.2 Products offered 279
14.1.1.3 Recent developments 279
14.1.1.3.1 Product launches/Approvals/Enhancements 279
14.1.1.4 MnM view 280
14.1.1.4.1 Key strengths 280
14.1.1.4.2 Strategic choices 280
14.1.1.4.3 Weaknesses & competitive threats 280
14.1.2 ZOETIS SERVICES LLC 281
14.1.2.1 Business overview 281
14.1.2.2 Products offered 282
14.1.2.3 Recent developments 283
14.1.2.3.1 Deals 283
14.1.2.3.2 Expansions 283
14.1.2.3.3 Other developments 284
14.1.2.4 MnM view 284
14.1.2.4.1 Key strengths 284
14.1.2.4.2 Strategic choices 284
14.1.2.4.3 Weaknesses & competitive threats 285
14.1.3 THERMO FISHER SCIENTIFIC INC. 286
14.1.3.1 Business overview 286
14.1.3.2 Products offered 287
14.1.3.3 MnM view 290
14.1.3.3.1 Key strengths 290
14.1.3.3.2 Strategic choices 291
14.1.3.3.3 Weaknesses & competitive threats 291
14.1.4 ANTECH DIAGNOSTICS, INC. 292
14.1.4.1 Business overview 292
14.1.4.2 Products offered 293
14.1.4.3 Recent developments 293
14.1.4.3.1 Product launches/Approvals/Enhancements 293
14.1.4.3.2 Expansions 294
14.1.4.4 MnM view 294
14.1.4.4.1 Key strengths 294
14.1.4.4.2 Strategic choices 294
14.1.4.4.3 Weaknesses & competitive threats 295
14.1.5 BIONOTE 296
14.1.5.1 Business overview 296
14.1.5.2 Products offered 296
14.1.5.3 Recent developments 298
14.1.5.4 Product launches/Approvals/Enhancements 298
14.1.5.4.1 Deals 299
14.1.5.5 MnM view 299
14.1.5.5.1 Key strengths 299
14.1.5.5.2 Strategic choices 299
14.1.5.5.3 Weaknesses & competitive threats 300
14.1.6 INNOVATIVE DIAGNOSTICS 301
14.1.6.1 Business overview 301
14.1.6.2 Products offered 301
14.1.6.3 Recent developments 302
14.1.6.3.1 Other developments 302
14.1.7 BIOMÉRIEUX 303
14.1.7.1 Business overview 303
14.1.7.2 Products offered 304
14.1.7.3 Recent developments 305
14.1.7.3.1 Product launches/Approvals/Enhancements 305
14.1.8 INDICAL BIOSCIENCE GMBH 306
14.1.8.1 Business overview 306
14.1.8.2 Products offered 306
14.1.8.3 Recent developments 308
14.1.8.3.1 Product launches/Approvals/Enhancements 308
14.1.9 VIRBAC 309
14.1.9.1 Business overview 309
14.1.9.2 Products offered 310
14.1.9.3 Recent developments 311
14.1.9.3.1 Deals 311
14.1.9.3.2 Expansions 311
14.1.10 MEGACOR DIAGNOSTIK GMBH 312
14.1.10.1 Business overview 312
14.1.10.2 Products offered 312
14.1.10.3 Recent developments 315
14.1.10.3.1 Product launches/Approvals/Enhancements 315
14.1.11 BIOGAL 316
14.1.11.1 Business overview 316
14.1.11.2 Products offered 316
14.1.12 RING BIOTECHNOLOGY CO., LTD. 318
14.1.12.1 Business overview 318
14.1.12.2 Products offered 318
14.1.12.3 Recent developments 325
14.1.12.3.1 Product launches/Approvals/Enhancements 325
14.1.12.3.2 Other developments 325
14.1.13 AGROLABO S.P.A. 326
14.1.13.1 Business overview 326
14.1.13.2 Products offered 326
14.1.14 ENALEES 328
14.1.14.1 Business overview 328
14.1.14.2 Products offered 328
14.1.14.3 Recent developments 331
14.1.14.3.1 Product launches/Approvals/Enhancements 331
14.1.14.3.2 Deals 331
14.1.14.3.3 Expansions 332
14.1.14.3.4 Other developments 333
14.1.15 BIOPANDA REAGENTS LTD 334
14.1.15.1 Business overview 334
14.1.15.2 Products offered 334
14.2 OTHER PLAYERS 338
14.2.1 FASSISI, GMBH 338
14.2.2 SKYER, INC. 339
14.2.3 GOLD STANDARD DIAGNOSTICS 340
14.2.4 BIO-X DIAGNOSTICS S.A. 341
14.2.5 AFFIGEN INC. 342
14.2.6 ALVEO TECHNOLOGIES 343
14.2.7 FLUXERGY INC. 344
14.2.8 WOODLEY EQUIPMENT COMPANY LTD 345
14.2.9 UBIO BIOTECHNOLOGY SYSTEMS PVT. LTD. 346
14.2.10 CORIS BIOCONCEPT 347
15 RESEARCH METHODOLOGY 348
15.1 RESEARCH APPROACH 348
15.2 RESEARCH METHODOLOGY DESIGN 348
15.2.1 SECONDARY RESEARCH 349
15.2.1.1 Key data from secondary sources 350
15.2.2 PRIMARY DATA 350
15.2.2.1 Key data from primary sources 351
15.2.2.2 Key industry insights 352
15.3 MARKET SIZE ESTIMATION 354
15.3.1 BOTTOM-UP APPROACH 360
15.4 DATA TRIANGULATION 361
15.5 MARKET SHARE ESTIMATION 362
15.6 RESEARCH ASSUMPTIONS 362

15.7 RESEARCH LIMITATIONS 362
15.7.1 METHODOLOGY-RELATED LIMITATIONS 362
15.7.2 SCOPE-RELATED LIMITATIONS 363
15.8 RISK ASSESSMENT 363
16 APPENDIX 364
16.1 DISCUSSION GUIDE 364
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 368
16.3 CUSTOMIZATION OPTIONS 370
16.3.1 PRODUCT ANALYSIS 370
16.3.2 COMPANY INFORMATION 370
16.3.3 GEOGRAPHIC ANALYSIS 370
16.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS 370
16.3.5 COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT TYPE 370
16.3.6 BY PRODUCT TYPE MARKET SHARE ANALYSIS (TOP 5 PLAYERS) 370
16.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS 370
16.4 RELATED REPORTS 371
16.5 AUTHOR DETAILS 372

LIST OF TABLES

TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 36
TABLE 2 NUMBER OF US HOUSEHOLDS OWNING PETS, BY ANIMAL TYPE, 2024 (MILLION) 51
TABLE 3 VETERINARY POC DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 61
TABLE 4 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (USD BILLION) 64
TABLE 5 PRICING TREND OF VETERINARY POC DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2023–2025 69
TABLE 6 PRICING TREND OF PCR KITS, BY REGION, 2023−2025 70
TABLE 7 PRICING TREND OF IMMUNODIAGNOSTIC (RAPID TEST) VETERINARY POC PRODUCTS, BY REGION, 2023−2025 70
TABLE 8 IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 72
TABLE 9 EXPORT DATA FOR HS CODE 3822, BY COUNTRY, 2021–2025 (USD THOUSAND) 72
TABLE 10 VETERINARY POC DIAGNOSTICS MARKET: MAJOR CONFERENCES AND EVENTS IN 2026–2027 73
TABLE 11 CASE STUDY 1: ADVANCED DIAGNOSTIC SOLUTIONS FOR POULTRY DISEASES: TARGETING COCCIDIOSIS AND SALMONELLA DETECTION USING AI TECHNOLOGIES 76
TABLE 12 CASE STUDY 2: AI-POWERED DIAGNOSTIC PLATFORM WITH DIGITAL MICROSCOPY AND DEEP LEARNING: TARGETING PARASITE DETECTION 77
TABLE 13 CASE STUDY 3: MULTIPLEX ELISA-BASED POC DIAGNOSTIC TEST: TARGETING VECTOR-BORNE DISEASE DETECTION 77
TABLE 14 US-ADJUSTED RECIPROCAL TARIFF RATES 79
TABLE 15 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR VETERINARY POC DIAGNOSTIC PRODUCTS 79
TABLE 16 NORTH AMERICA: IMPACT OF US TARIFFS ON CANADA 80
TABLE 17 ASIA PACIFIC: IMPACT OF US TARIFFS ON CHINA, JAPAN, AND INDIA 80
TABLE 18 EUROPE: IMPACT OF US TARIFFS ON GERMANY AND UK 81
TABLE 19 LATIN AMERICA: IMPACT OF US TARIFFS ON MEXICO 81
TABLE 20 VETERINARY POC DIAGNOSTICS MARKET: MAJOR PATENTS 89
TABLE 21 KEY COMPANIES ADOPTING AI-POWERED VETERINARY POC DIAGNOSTIC PRODUCTS 93
TABLE 22 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
TABLE 23 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
TABLE 24 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 25 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 26 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
TABLE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY POC DIAGNOSTIC PRODUCTS 101
TABLE 28 KEY BUYING CRITERIA FOR TOP 3 END USERS 102
TABLE 29 VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 107
TABLE 30 VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 108
TABLE 31 KEY PLAYERS PROVIDING CONSUMABLES 109
TABLE 32 CONSUMABLES: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 110
TABLE 33 CONSUMABLES: VETERINARY POC DIAGNOSTICS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 111
TABLE 34 KEY PLAYERS PROVIDING INSTRUMENTS 112
TABLE 35 INSTRUMENTS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 113
TABLE 36 INSTRUMENTS: VETERINARY POC DIAGNOSTICS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS) 114
TABLE 37 VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 116
TABLE 38 KEY PLAYERS PROVIDING VETERINARY POC DIAGNOSTICS FOR COMPANION ANIMALS 117
TABLE 39 COMPANION ANIMALS: VETERINARY POC DIAGNOSTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 118
TABLE 40 COMPANION ANIMALS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 118
TABLE 41 DOG: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 120
TABLE 42 CAT: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 121
TABLE 43 HORSE: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 123
TABLE 44 OTHER COMPANION ANIMALS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 124
TABLE 45 KEY PLAYERS PROVIDING VETERINARY POC DIAGNOSTICS FOR LIVESTOCK 126
TABLE 46 LIVESTOCK: VETERINARY POC DIAGNOSTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 127
TABLE 47 LIVESTOCK: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127
TABLE 48 CATTLE: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129
TABLE 49 PIG: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 130
TABLE 50 POULTRY: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132
TABLE 51 OTHER LIVESTOCK: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 133
TABLE 52 VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 136
TABLE 53 KEY PLAYERS PROVIDING IMMUNODIAGNOSTICS 137
TABLE 54 IMMUNODIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 138
TABLE 55 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS 140
TABLE 56 MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 140
TABLE 57 MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141
TABLE 58 PCR-BASED MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 142
TABLE 59 ISOTHERMAL AMPLIFICATION MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 144
TABLE 60 CRISPR-BASED MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145
TABLE 61 OTHER TECHNOLOGIES: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 147
TABLE 62 GLOBAL VETERINARY POC DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 149
TABLE 63 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS) 152
TABLE 64 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 153
TABLE 65 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 153
TABLE 66 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 153
TABLE 67 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 154
TABLE 68 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 154
TABLE 69 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 154
TABLE 70 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 155
TABLE 71 US: KEY MACRO INDICATORS 156
TABLE 72 US: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 156
TABLE 73 US: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 156
TABLE 74 US: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 157
TABLE 75 US: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 157
TABLE 76 US: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 157
TABLE 77 US: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 158
TABLE 78 CANADA: KEY MACRO INDICATORS 159
TABLE 79 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 159
TABLE 80 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 159
TABLE 81 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 160
TABLE 82 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 160
TABLE 83 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 160
TABLE 84 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 161
TABLE 85 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS) 162
TABLE 86 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 163
TABLE 87 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 163
TABLE 88 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 164
TABLE 89 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 164
TABLE 90 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 164
TABLE 91 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 165
TABLE 92 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 165
TABLE 93 GERMANY: KEY MACRO INDICATORS 166
TABLE 94 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 167
TABLE 95 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 167
TABLE 96 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 167
TABLE 97 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 168
TABLE 98 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 168
TABLE 99 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 168
TABLE 100 UK: KEY MACRO INDICATORS 170
TABLE 101 UK: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 170
TABLE 102 UK: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 170
TABLE 103 UK: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 171
TABLE 104 UK: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 171
TABLE 105 UK: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 171
TABLE 106 UK: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 172
TABLE 107 FRANCE: KEY MACRO INDICATORS 172
TABLE 108 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 173
TABLE 109 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 173
TABLE 110 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 173
TABLE 111 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 174
TABLE 112 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 174
TABLE 113 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 174
TABLE 114 ITALY: KEY MACRO INDICATORS 175
TABLE 115 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 176
TABLE 116 ITALY VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 176
TABLE 117 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 176
TABLE 118 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 177
TABLE 119 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 177
TABLE 120 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 177
TABLE 121 SPAIN: KEY MACRO INDICATORS 178
TABLE 122 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 178
TABLE 123 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 179
TABLE 124 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 179
TABLE 125 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 179
TABLE 126 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 180
TABLE 127 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 180
TABLE 128 NETHERLANDS: KEY MACRO INDICATORS 181
TABLE 129 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 181
TABLE 130 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 182
TABLE 131 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 182
TABLE 132 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 182
TABLE 133 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 183
TABLE 134 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 183
TABLE 135 POLAND: KEY MACRO INDICATORS 184
TABLE 136 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 184
TABLE 137 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 185
TABLE 138 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 185
TABLE 139 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 185
TABLE 140 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 186
TABLE 141 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 186
TABLE 142 SWEDEN: KEY MACRO INDICATORS 187
TABLE 143 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 187
TABLE 144 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 187
TABLE 145 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 188
TABLE 146 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 188
TABLE 147 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 188
TABLE 148 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 189
TABLE 149 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 189
TABLE 150 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 190
TABLE 151 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 190
TABLE 152 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 190
TABLE 153 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 191
TABLE 154 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 191
TABLE 155 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS) 194
TABLE 156 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 195
TABLE 157 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 195
TABLE 158 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 196
TABLE 159 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 196
TABLE 160 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 196
TABLE 161 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 197
TABLE 162 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 197
TABLE 163 CHINA: KEY MACRO INDICATORS 198
TABLE 164 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 198
TABLE 165 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 199
TABLE 166 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 199
TABLE 167 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 199
TABLE 168 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 200
TABLE 169 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 200
TABLE 170 JAPAN: KEY MACRO INDICATORS 201
TABLE 171 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 202
TABLE 172 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 202
TABLE 173 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 202
TABLE 174 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 203
TABLE 175 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 203
TABLE 176 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 203
TABLE 177 INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS) 205
TABLE 178 INDIA: KEY MACRO INDICATORS 205
TABLE 179 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 205
TABLE 180 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 206
TABLE 181 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 206
TABLE 182 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 206
TABLE 183 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 207
TABLE 184 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 207
TABLE 185 AUSTRALIA: KEY MACRO INDICATORS 208
TABLE 186 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 208
TABLE 187 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 209
TABLE 188 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 209
TABLE 189 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 209
TABLE 190 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 210
TABLE 191 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 210
TABLE 192 SOUTH KOREA: KEY MACRO INDICATORS 211
TABLE 193 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 211
TABLE 194 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 211
TABLE 195 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 212
TABLE 196 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 212
TABLE 197 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 212
TABLE 198 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 213
TABLE 199 NEW ZEALAND: KEY MACRO INDICATORS 213
TABLE 200 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 214
TABLE 201 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 214
TABLE 202 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 214
TABLE 203 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 215
TABLE 204 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 215
TABLE 205 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 215
TABLE 206 THAILAND: KEY MACRO INDICATORS 216
TABLE 207 THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 217
TABLE 208 THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 217
TABLE 209 THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 217
TABLE 210 THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 218
TABLE 211 THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 218
TABLE 212 THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 218
TABLE 213 REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 219
TABLE 214 REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 219
TABLE 215 REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 220
TABLE 216 REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 220
TABLE 217 REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 221
TABLE 218 REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 221
TABLE 219 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS) 222
TABLE 220 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 223
TABLE 221 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 223
TABLE 222 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 223
TABLE 223 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 224
TABLE 224 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 224
TABLE 225 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 224
TABLE 226 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 225
TABLE 227 BRAZIL: KEY MACRO INDICATORS 226
TABLE 228 BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 226
TABLE 229 BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 226
TABLE 230 BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 227
TABLE 231 BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 227
TABLE 232 BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 227
TABLE 233 BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 228
TABLE 234 MEXICO: KEY MACRO INDICATORS 228
TABLE 235 MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 229
TABLE 236 MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 229
TABLE 237 MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 229
TABLE 238 MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 230
TABLE 239 MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 230
TABLE 240 MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 230
TABLE 241 ARGENTINA: KEY MACRO INDICATORS 231
TABLE 242 ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 232
TABLE 243 ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 232
TABLE 244 ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 232
TABLE 245 ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 233
TABLE 246 ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 233
TABLE 247 ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 233
TABLE 248 REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 234
TABLE 249 REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 234
TABLE 250 REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 235
TABLE 251 REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 235
TABLE 252 REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 235
TABLE 253 REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 236
TABLE 254 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS) 237
TABLE 255 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 238
TABLE 256 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 238
TABLE 257 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 238
TABLE 258 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 239
TABLE 259 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 239
TABLE 260 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 239
TABLE 261 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 240
TABLE 262 GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 240
TABLE 263 GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 241
TABLE 264 GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 241
TABLE 265 GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 241
TABLE 266 GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 242
TABLE 267 GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 242
TABLE 268 GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 242
TABLE 269 KINGDOM OF SAUDI ARABIA (KSA): KEY MACRO INDICATORS 243
TABLE 270 KINGDOM OF SAUDI ARABIA (KSA): VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 243
TABLE 271 KINGDOM OF SAUDI ARABIA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 244
TABLE 272 KINGDOM OF SAUDI ARABIA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 244
TABLE 273 KINGDOM OF SAUDI ARABIA (KSA): VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 244
TABLE 274 KINGDOM OF SAUDI ARABIA (KSA): VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 245
TABLE 275 KINGDOM OF SAUDI ARABIA (KSA): VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 245
TABLE 276 UNITED ARAB EMIRATES (UAE): KEY MACRO INDICATORS 246
TABLE 277 UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 246
TABLE 278 UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 246
TABLE 279 UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 247
TABLE 280 UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 247
TABLE 281 UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 247
TABLE 282 UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 248
TABLE 283 REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 248
TABLE 284 REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 249
TABLE 285 REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 249
TABLE 286 REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 249
TABLE 287 REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 250
TABLE 288 REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 250
TABLE 289 REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 251
TABLE 290 REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 251
TABLE 291 REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION) 251
TABLE 292 REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION) 252
TABLE 293 REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 252
TABLE 294 REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION) 252
TABLE 295 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET 253
TABLE 296 VETERINARY POC DIAGNOSTICS MARKET: DEGREE OF COMPETITION 258
TABLE 297 US VETERINARY POC DIAGNOSTICS MARKET: DEGREE OF COMPETITION 259
TABLE 298 EUROPE VETERINARY POC DIAGNOSTICS MARKET: DEGREE OF COMPETITION 260
TABLE 299 VETERINARY POC DIAGNOSTICS MARKET: REGION FOOTPRINT 264
TABLE 300 VETERINARY POC DIAGNOSTICS MARKET: PRODUCT FOOTPRINT 265
TABLE 301 VETERINARY POC DIAGNOSTICS MARKET: TECHNOLOGY FOOTPRINT 266
TABLE 302 VETERINARY POC DIAGNOSTICS MARKET: ANIMAL TYPE FOOTPRINT 267
TABLE 303 VETERINARY POC DIAGNOSTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 269
TABLE 304 VETERINARY POC DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 270
TABLE 305 VETERINARY POC DIAGNOSTICS MARKET: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS, JANUARY 2022–MAY 2026 273
TABLE 306 VETERINARY POC DIAGNOSTICS MARKET: DEALS, JANUARY 2022–APRIL 2026 274
TABLE 307 VETERINARY POC DIAGNOSTICS MARKET:
EXPANSIONS, JANUARY 2022–APRIL 2026 275
TABLE 308 VETERINARY POC DIAGNOSTICS MARKET: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2026 276
TABLE 309 IDEXX LABORATORIES, INC.: COMPANY OVERVIEW 277
TABLE 310 IDEXX LABORATORIES, INC.: PRODUCTS OFFERED 279
TABLE 311 IDEXX LABORATORIES, INC.: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS 279
TABLE 312 ZOETIS SERVICES LLC: COMPANY OVERVIEW 281
TABLE 313 ZOETIS SERVICES LLC: PRODUCTS OFFERED 282
TABLE 314 ZOETIS SERVICES LLC: DEALS 283
TABLE 315 ZOETIS SERVICES LLC: EXPANSIONS 283
TABLE 316 ZOETIS SERVICES LLC: OTHER DEVELOPMENTS 284
TABLE 317 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 286
TABLE 318 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 287
TABLE 319 ANTECH DIAGNOSTICS, INC.: COMPANY OVERVIEW 292
TABLE 320 ANTECH DIAGNOSTICS, INC.: PRODUCTS OFFERED 293
TABLE 321 ANTECH DIAGNOSTICS, INC.: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS 293
TABLE 322 ANTECH DIAGNOSTICS, INC.: EXPANSIONS 294
TABLE 323 BIONOTE: COMPANY OVERVIEW 296
TABLE 324 BIONOTE: PRODUCTS OFFERED 296
TABLE 325 BIONOTE: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS 298
TABLE 326 BIONOTE: DEALS 299
TABLE 327 INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW 301
TABLE 328 INNOVATIVE DIAGNOSTICS: PRODUCTS OFFERED 301
TABLE 329 INNOVATIVE DIAGNOSTICS: OTHER DEVELOPMENTS 302
TABLE 330 BIOMÉRIEUX: COMPANY OVERVIEW 303
TABLE 331 BIOMÉRIEUX: PRODUCTS OFFERED 304
TABLE 332 BIOMÉRIEUX: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS 305
TABLE 333 INDICAL BIOSCIENCE GMBH: COMPANY OVERVIEW 306
TABLE 334 INDICAL BIOSCIENCE GMBH: PRODUCTS OFFERED 306
TABLE 335 INDICAL BIOSCIENCE GMBH: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS 308
TABLE 336 VIRBAC: COMPANY OVERVIEW 309
TABLE 337 VIRBAC: PRODUCTS OFFERED 310
TABLE 338 VIRBAC: DEALS 311
TABLE 339 VIRBAC: EXPANSIONS 311
TABLE 340 MEGACOR DIAGNOSTIK GMBH: COMPANY OVERVIEW 312
TABLE 341 MEGACOR DIAGNOSTIK GMBH: PRODUCTS OFFERED 312
TABLE 342 MEGACOR DIAGNOSTIK GMBH: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS 315
TABLE 343 BIOGAL: COMPANY OVERVIEW 316
TABLE 344 BIOGAL: PRODUCTS OFFERED 316
TABLE 345 RING BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW 318
TABLE 346 RING BIOTECHNOLOGY CO., LTD.: PRODUCTS OFFERED 318
TABLE 347 RING BIOTECHNOLOGY CO., LTD.: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS 325
TABLE 348 RING BIOTECHNOLOGY CO., LTD.: OTHER DEVELOPMENTS 325
TABLE 349 AGROLABO S.P.A.: COMPANY OVERVIEW 326
TABLE 350 AGROLABO S.P.A.: PRODUCTS OFFERED 326
TABLE 351 ENALEES: COMPANY OVERVIEW 328
TABLE 352 ENALEES: PRODUCTS OFFERED 328
TABLE 353 ENALEES: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS 331
TABLE 354 ENALEES: DEALS 331
TABLE 355 ENALEES: EXPANSIONS 332
TABLE 356 ENALEES: OTHER DEVELOPMENTS 333
TABLE 357 BIOPANDA REAGENTS LTD: COMPANY OVERVIEW 334
TABLE 358 BIOPANDA REAGENTS LTD: PRODUCTS OFFERED 334
TABLE 359 FASSISI, GMBH: COMPANY OVERVIEW 338
TABLE 360 SKYER, INC.: COMPANY OVERVIEW 339
TABLE 361 GOLD STANDARD DIAGNOSTICS: COMPANY OVERVIEW 340
TABLE 362 BIO-X DIAGNOSTICS S.A.: COMPANY OVERVIEW 341
TABLE 363 AFFIGEN INC.: COMPANY OVERVIEW 342
TABLE 364 ALVEO TECHNOLOGIES: COMPANY OVERVIEW 343
TABLE 365 FLUXERGY INC.: COMPANY OVERVIEW 344
TABLE 366 WOODLEY EQUIPMENT COMPANY LTD: COMPANY OVERVIEW 345
TABLE 367 UBIO BIOTECHNOLOGY SYSTEMS PVT. LTD.: COMPANY OVERVIEW 346
TABLE 368 CORIS BIOCONCEPT: COMPANY OVERVIEW 347
TABLE 369 VETERINARY POC DIAGNOSTICS MARKET: ASSUMPTIONS ANALYSIS 362
TABLE 370 VETERINARY POC DIAGNOSTICS MARKET: RISK ASSESSMENT ANALYSIS 363

LIST OF FIGURES

FIGURE 1 VETERINARY POC DIAGNOSTICS MARKET SEGMENTATION AND REGIONAL SCOPE 34
FIGURE 2 MARKET SCENARIO 38
FIGURE 3 GLOBAL VETERINARY POC DIAGNOSTICS MARKET, 2024–2031 39
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET, 2020–2025 39
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF VETERINARY POC DIAGNOSTICS MARKET 40
FIGURE 6 HIGH-GROWTH SEGMENTS IN VETERINARY POC DIAGNOSTICS MARKET,
2026–2031 41
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN VETERINARY POC DIAGNOSTICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 42
FIGURE 8 INCREASING DEMAND FOR RAPID AND ON-SITE DIAGNOSTICS TO FUEL MARKET GROWTH 44
FIGURE 9 CONSUMABLES SEGMENT AND CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 45
FIGURE 10 ASIA PACIFIC TO EXHIBIT HIGHEST CAGR DURING FORECAST PERIOD 46
FIGURE 11 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 46
FIGURE 12 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 47
FIGURE 13 VETERINARY POC DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 48
FIGURE 14 PET EXPENDITURE IN US, DOGS VS. CATS, 2024 (USD) 53
FIGURE 15 VETERINARY POC DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 61
FIGURE 16 VETERINARY POC DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS 67
FIGURE 17 VETERINARY POC DIAGNOSTIC ECOSYSTEM ANALYSIS 68
FIGURE 18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 75
FIGURE 19 VETERINARY POC DIAGNOSTICS MARKET: INVESTMENT AND FUNDING SCENARIO 76
FIGURE 20 VETERINARY POC DIAGNOSTICS MARKET: NUMBER OF PATENTS GRANTED AND APPLIED (JANUARY 2015–MAY 2026) 88
FIGURE 21 TOP APPLICANT COUNTRIES AND REGIONS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PATENTS (JANUARY 2015–FEBRUARY 2026) 89
FIGURE 22 ADOPTION OF AI-POWERED DIAGNOSTIC SOLUTIONS FOR DISEASE TREND IDENTIFICATION AND TREATMENT OPTIMIZATION 92
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY POC DIAGNOSTIC PRODUCTS 101
FIGURE 24 KEY BUYING CRITERIA FOR TOP 3 END USERS 102
FIGURE 25 VETERINARY POC DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT 149
FIGURE 26 EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN
NORTH AMERICA, 2012–2030 151
FIGURE 27 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET SNAPSHOT 152
FIGURE 28 ASIA PACIFIC: DOG POPULATION GROWTH, BY COUNTRY, 2024 192
FIGURE 29 ASIA PACIFIC: CAT POPULATION GROWTH, BY COUNTRY, 2024 193
FIGURE 30 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET SNAPSHOT 194
FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2021−2025) 256
FIGURE 32 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2025) 257
FIGURE 33 US MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2025) 259
FIGURE 34 EUROPE MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2025) 260
FIGURE 35 VETERINARY POC DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 262
FIGURE 36 VETERINARY POC DIAGNOSTICS MARKET: COMPANY FOOTPRINT 263
FIGURE 37 VETERINARY POC DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 268
FIGURE 38 VETERINARY POC DIAGNOSTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 271
FIGURE 39 R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET, 2022−2025 272
FIGURE 40 EV/EBITDA OF KEY VENDORS 272
FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 273
FIGURE 42 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT 278
FIGURE 43 ZOETIS SERVICES LLC: COMPANY SNAPSHOT 282
FIGURE 44 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 287
FIGURE 45 BIOMÉRIEUX: COMPANY SNAPSHOT 304
FIGURE 46 VIRBAC: COMPANY SNAPSHOT 310
FIGURE 47 VETERINARY POC DIAGNOSTICS MARKET: RESEARCH DESIGN 348
FIGURE 48 DATA OBTAINED FROM SECONDARY SOURCES 350
FIGURE 49 PRIMARY SOURCES 350
FIGURE 50 DATA OBTAINED FROM PRIMARY SOURCES 351
FIGURE 51 EXPERT INSIGHTS 352
FIGURE 52 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE) 352
FIGURE 53 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION (DEMAND SIDE) 353
FIGURE 54 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 353
FIGURE 55 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 354
FIGURE 56 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC. 355
FIGURE 57 REVENUE ANALYSIS OF TOP 5 COMPANIES: VETERINARY POC DIAGNOSTICS MARKET (2024) 355
FIGURE 58 VETERINARY POC DIAGNOSTICS MARKET: DEMAND-SIDE ANALYSIS 357
FIGURE 59 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY POC DIAGNOSTICS MARKET (2026–2031) 358
FIGURE 60 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 359
FIGURE 61 TOP-DOWN APPROACH 359
FIGURE 62 BOTTOM-UP APPROACH 360
FIGURE 63 MARKET DATA TRIANGULATION METHODOLOGY 361

---

---